Epilepsy Monitoring Devices Market | Growing Innovative Products and Wearable Devices

According to Precision Business Insights (PBI), the latest report, the epilepsy monitoring devices market is expected to be worth USD 525 million in 2022, growing at an 4.9% CAGR from 2022 to 2028. The primary driver of the expansion of the global epilepsy monitoring devices market includes the increasing prevalence of epilepsy and the incidence of head injuries, brain cancer, and infections, the rise in research & development activities, government initiatives, and the awareness about epilepsy monitoring devices.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/epilepsy-monitoring-devices-market/

Electroencephalogram (EEG) devices Segment to Dominate the Epilepsy monitoring devices Market:
Amongst product types, Electroencephalogram (EEG) devices segment held a considerable market during the estimated period. Electroencephalogram (EEG) devices are used to get abnormal EEG patterns for accurate predictions for seizure recurrence. So, continuous monitoring of patients through EEG devices is essential. Hence, there is a massive demand for EEG devices for epilepsy monitoring. The wearable devices can be segmented into watches, camera devices, mattress devices, anti-suffocation pillows, and others. Wearable epileptic device technology has gained substantial popularity in recent years. Conventional devices and wearable devices are the major market share holder of the market and are expected to drive the growth of the global epilepsy monitoring market in the forecasted years.

Asia Pacific Epilepsy Monitoring Devices Market:
The global epilepsy device market, based on region, is segmented into America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is expected to increase in the global epilepsy monitoring devices market over the forecast period. It is projected to grow at a significant CAGR in the coming years. The Asia Pacific market is developing rapidly due to the emergence of new players, and the high prevalence of epilepsy in the region. North America held a considerable market share during the estimated period due to developed health care facilities, government policies, major global companies in the region, and rising epilepsy cases.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=58564

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global epilepsy monitoring devices market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance,In July 2022, Marinus Pharmaceuticals announced the launch of ZTALMY (ganaxolone) for seizures associated with CDKL5 deficiency disorder. In Feb 2022, Epitel, a digital health company developing a wearable, wireless EEG monitoring platform for seizure detection, announced closing a $12.5 million Series financing for the wearable. Epitel received FDA clearance for its first product, a wireless and wearable EEG (brain wave monitor) sensor, and remote access software known as REMI for use within hospital emergency rooms and critical care units.

The epilepsy monitoring devices market is segmented based on product, technology, end-user, and geography.
Based on the product, the market is segmented into the following:
• Wearable Devices
• Conventional Devices
• Implantable Devices

Based on the technology, the market is segmented into the following:
• Vagus Nerve Stimulation (VNS)
• Responsive Neurostimulation
• Deep Brain Stimulation
• Accelerometry

Based on the end user, the market is segmented into the following:
• Hospitals
• Ambulatory Surgery Centers and clinic
• Neurology Centers
• Diagnostic Centers
• Home Care Settings

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=58564

Key players' profiles in the epilepsy monitoring devices market report are Koninklijke Philips N.V, Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), and Neurosoft (Russia).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.